CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205473709
- Phone
- 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy CEO and CFO bought 29,000 shares at $9.13 ($264,770)
- 10-K/A Report 10-K/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy CEO and CFO bought 8,000 shares at $7.13 ($57,040)
- 4 Open-market buy CEO and CFO bought 12,000 shares at $7.91 ($94,920)
- 4 Open-market buy CEO and CFO bought 12,000 shares at $8.33 ($99,960)
- 4 Open-market buy CEO and CFO bought 4,500 shares at $10.90 ($49,050)
- 4 Open-market buy CEO and CFO bought 6,000 shares at $8.55 ($51,300)
Page 8 of 14 · 279 filings